Showing results (441-450 of 475) with videos related to

Sort By:
Pageof 48
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 21, 2016
Baseline Peripheral Blood Biomarkers Associated with Clinical Outcome of Advanced Melanoma Patients Treated with IpilimumabAlexander Martens, Kilian Wistuba-Hamprecht, Marnix Geukes Foppen, et al.
Nature Medicine|July 3, 2026
Immune aging biomarkers for clinical trialsAndrea Cipriano, Jamie Justice, Jesse R Poganik, et al.
Mechanisms of Ageing and Development|September 19, 2020
The conundrum of human immune system "senescence"Graham Pawelec, Anne Bronikowski, Stephen C Cunnane, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 18, 2020
Advanced Age Increases Immunosuppression in the Brain and Decreases Immunotherapeutic Efficacy in Subjects with GlioblastomaErik Ladomersky, Lijie Zhai, Kristen L Lauing, et al.
American Journal of Ophthalmology Case Reports|February 12, 2026
Bilateral hemorrhagic occlusive retinal vasculitis and panuveitis following intravitreal faricimab injection: A clinicopathologic case studyNegin Yavari, Ankur Sudhir Gupta, Andreas Mitsios, et al.
The Yale Journal of Biology and Medicine|December 20, 2024
Tocilizumab for Cystoid Macular Edema Secondary to Immune Recovery Uveitis in a Patient with Contraindications to Long-Term Systemic CorticosteroidBa Trung Nguyen, Jia-Horung Hung, Zheng Xian Thng, et al.
The British Journal of Ophthalmology|December 25, 2025
Analysis of full-field electroretinography parameters and potential for monitoring functional retinal deterioration in unilateral retinal vasculitisSungwho Park, Woong-Sun Yoo, Irmak Karaca, et al.
Journal of Ophthalmic Inflammation and Infection|March 27, 2025
IgG4-related ophthalmic disease presenting as posterior scleritis in a pediatric patientIrmak Karaca, Albert John Bromeo, Azadeh Mobasserian, et al.
Journal for Immunotherapy of Cancer|January 20, 2026
Vδ1 T-cell subset appears to be responsive to PD-1 blockade therapy and is associated with survival in melanomaNicola Herold, Jonas Bochem, Johanna Leyens, et al.
Pageof 48